Company: CYTK
Filing Date: 2025-04-10
Form Type: DEF 14A
Source: 0001140361-25-013167
Chunk: 91

Company: CYTOKINETICS INC
Filing Date: 2025-04-10
Form: DEF 14A
Chunk 91
---
 in Prior 
 Years that Vested in 
             the Year 
           $(709,832) |     | Fair Value at the End  
 of the Prior Year of   
 Equity Awards that     
 Failed to Meet Vesting 
 Conditions in the Year 
 $(1,099,971)           |     |     Aggregate 
 Equity Awards 
    Adjustment 
    $(427,101) |
|:-----|:----|----------------:|:----|---------------------:|:----|-------------------:|:----|---------------------:|:----|:-----------------------|:----|--------------:|
| 2023 |     |      $4,386,915 |     |           $1,876,679 |     |           $201,402 |     |           $(689,660) |     | $—                     |     |    $5,775,336 |
| 2022 |     |      $1,698,148 |     |           $(451,058) |     |           $211,375 |     |           $(182,059) |     | $(475,330)             |     |      $801,075 |
| 2021 |     |      $3,875,707 |     |           $1,580,194 |     |           $140,931 |     |             $211,963 |     | $—                     |     |    $5,808,795 |
| 2020 |     |      $1,477,028 |     |             $679,612 |     |           $172,143 |     |             $330,603 |     | $—                     |     |    $2,659,384 |

| (5) | Cumulative TSR is calculated by the difference between the Company’s share price at the end and the beginning of the measurement period by the Company’s share price at the beginning of the measurement period. “Measurement period” is defined as: for 2020, the one-year period from market close December 31, 2019 through December 31, 2020; for 2021, the two-year period from market close on December 31, 2019 through December 31, 2021; for 2022, the three-year period from market close December 31, 2019 through December 31, 2022; for 2023, the four-year period from market close December 31, 2019 through December 31, 2023;